These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9331095)

  • 1. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.
    Yang W; Barth RF; Adams DM; Soloway AH
    Cancer Res; 1997 Oct; 57(19):4333-9. PubMed ID: 9331095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
    Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
    Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors.
    Capala J; Barth RF; Bendayan M; Lauzon M; Adams DM; Soloway AH; Fenstermaker RA; Carlsson J
    Bioconjug Chem; 1996; 7(1):7-15. PubMed ID: 8741985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
    Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA
    Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
    Yang W; Wu G; Barth RF; Swindall MR; Bandyopadhyaya AK; Tjarks W; Tordoff K; Moeschberger M; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2008 Feb; 14(3):883-91. PubMed ID: 18245552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
    Wu G; Yang W; Barth RF; Kawabata S; Swindall M; Bandyopadhyaya AK; Tjarks W; Khorsandi B; Blue TE; Ferketich AK; Yang M; Christoforidis GA; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA
    Clin Cancer Res; 2007 Feb; 13(4):1260-8. PubMed ID: 17317838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.
    Wu G; Barth RF; Yang W; Chatterjee M; Tjarks W; Ciesielski MJ; Fenstermaker RA
    Bioconjug Chem; 2004; 15(1):185-94. PubMed ID: 14733599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
    Barth RF; Wu G; Yang W; Binns PJ; Riley KJ; Patel H; Coderre JA; Tjarks W; Bandyopadhyaya AK; Thirumamagal BT; Ciesielski MJ; Fenstermaker RA
    Appl Radiat Isot; 2004 Nov; 61(5):899-903. PubMed ID: 15308165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.
    Yang W; Barth RF; Leveille R; Adams DM; Ciesielski M; Fenstermaker RA; Capala J
    J Neurooncol; 2001 Oct; 55(1):19-28. PubMed ID: 11804279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
    Yang W; Barth RF; Wu G; Huo T; Tjarks W; Ciesielski M; Fenstermaker RA; Ross BD; Wikstrand CJ; Riley KJ; Binns PJ
    J Neurooncol; 2009 Dec; 95(3):355-365. PubMed ID: 19588228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
    Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
    Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
    Bohl Kullberg E; Carlsson J; Edwards K; Capala J; Sjöberg S; Gedda L
    Int J Oncol; 2003 Aug; 23(2):461-7. PubMed ID: 12851696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
    Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.
    Capala J; Barth RF; Bailey MQ; Fenstermaker RA; Marek MJ; Rhodes BA
    Bioconjug Chem; 1997; 8(3):289-95. PubMed ID: 9177833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.